ReviewFrontiers in pharmacology2025

Critical dysregulated signaling pathways in drug resistance: highlighting the repositioning of mebendazole for cancer therapy.

Amin Aliabadi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.